Expression of anion exchanger 1 is associated with tumor progress in human gastric cancer
Anion exchanger 1 (AE1) is a transmembrane glycoprotein which is abundantly expressed in erythrocyte plasma membrane and mediates the electroneutral exchange of Cl− and HCO3−. We previously reported that the AE1 protein was unexpectedly expressed in the gastric and colonic cancer and take part in the carcinogenesis of the cancer cells. The aim of the present study is to determine the potential clinical implications of AE1 expression in gastric carcinoma.
Immunohistochemistry assay was used to determine the expression of AE1 protein. The expression of AE1 in normal and malignant tissues from 286 patients with early and advanced gastric carcinoma was examined. The correlations of AE1 expression with clinicopathological parameters, including age, tumor size, location and subtypes, expression frequency, survival period and lymph metastasis were assessed by Chi-squared test and t test analysis.
AE1 immunoreactivity was negative in normal gastric tissue. Positive immunostaining of AE1 was detected in gastric carcinoma regardless of the location. AE1 was most frequently expressed in the gastric antrum carcinoma compared with gastric body cancer (P = 0.034). Expression of AE1 was significantly associated with bigger tumor size, deeper invasion, shorter survival period, and non-lymph metastasis. In para-cancer tissues of intestinal-type gastric cancer, the expression frequency of AE1 was higher than that in diffuse-type (P = 0.011).
The results showed a strong association of AE1 expression with the onset and progression of the gastric cancer and that may be helpful for improving the tumor classification and the treatment of cancer.
KeywordsAnion exchanger 1 Gastric carcinomas Immunohistochemistry Clinicopathological parameters
- Akel A, Wagner CA, Kovacikova J, Kasinathan RS, Kiedaisch V, Koka S, Alper SL, Bernhardt I, Wieder T, Huber SM, Lang F (2007) Enhanced suicidal death of erythrocytes from gene-targeted mice lacking the Cl−/HCO3 − exchanger AE1. Am J Physiol Cell Physiol 292(5):C1759–C1767. doi:10.1152/ajpcell.00158.2006 CrossRefPubMedGoogle Scholar
- Argent RH, Thomas RJ, Aviles-Jimenez F, Letley DP, Limb MC, El-Omar EM, Atherton JC (2008) Toxigenic Helicobacter pylori infection precedes gastric hypochlorhydria in cancer relatives, and H. pylori virulence evolves in these families. Clin Cancer Res 14(7):2227–2235. doi:10.1158/1078-0432.CCR-07-2022 CrossRefPubMedGoogle Scholar
- Ernst M, Najdovska M, Grail D, Lundgren-May T, Buchert M, Tye H, Matthews VB, Armes J, Bhathal PS, Hughes NR, Marcusson EG, Karras JG, Na S, Sedgwick JD, Hertzog PJ, Jenkins BJ (2008) STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice. J Clin Invest 118(5):1727–1738PubMedGoogle Scholar
- Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, Terao S, Amagai K, Hayashi S, Asaka M (2008) Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 372(9636):392–397. doi:10.1016/S0140-6736(08)61159-9 CrossRefPubMedGoogle Scholar
- Gawenis LR, Ledoussal C, Judd LM, Prasad V, Alper SL, Stuart-Tilley A, Woo AL, Grisham C, Sanford LP, Doetschman T, Miller ML, Shull GE (2004) Mice with a targeted disruption of the AE2 Cl−/HCO3 − exchanger are achlorhydric. J Biol Chem 279(29):30531–30539. doi:10.1074/jbc.M403779200 CrossRefPubMedGoogle Scholar
- Ito D, Koshino I, Arashiki N, Adachi H, Tomihari M, Tamahara S, Kurogi K, Amano T, Ono K, Inaba M (2006) Ubiquitylation-independent ER-associated degradation of an AE1 mutant associated with dominant hereditary spherocytosis in cattle. J Cell Sci 119:3602–3612. doi:10.1242/jcs.03101 CrossRefPubMedGoogle Scholar
- Louise MJ, Anastasia A, Carlos AR, Zachary S, Gary ES, Marian LM (2005) Gastric achlorhydria in H/K-ATPase-deficient (Atp4a(-/-)) mice causes severe hyperplasia, mucocystic metaplasia and upregulation of growth factors. J Gastroenterol Hepatol 20(8):1266–1278. doi:10.1111/j.1440-1746.2005.03867.x CrossRefGoogle Scholar